|
SELB
|
Selecta Biosciences, Inc.
|
US
|
NASDAQ
|
|
SNSE
|
Sensei Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
STAB
|
Statera Biopharma, Inc.
|
US
|
NASDAQ
|
|
SURF
|
Surface Oncology, Inc.
|
US
|
NASDAQ
|
|
TCBP
|
TC BioPharm (Holdings) plc
|
US
|
NASDAQ
|
|
TCRR
|
TCR2 Therapeutics Inc.
|
US
|
NASDAQ
|
|
THMO
|
ThermoGenesis Holdings, Inc.
|
US
|
NASDAQ
|
|
URGN
|
UroGen Pharma Ltd.
|
US
|
NASDAQ
|
|
XLO
|
Xilio Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IMU
|
Imugene Limited
|
AU
|
ASX
|
|
RGS
|
Regeneus Ltd
|
AU
|
ASX
|
|
ADXS
|
Advaxis Inc
|
US
|
OTC
|
|
ARGNF
|
Argen X Nv
|
US
|
OTC
|
|
BRCTF
|
Bioarctic Ab
|
US
|
OTC
|
|
CLLKF
|
Cellink Ab
|
US
|
OTC
|
|
CMVLF
|
Cellectis Romainvil
|
US
|
OTC
|
|
GLAXF
|
GlaxoSmithKline Plc
|
US
|
OTC
|
|
HNSBF
|
Hansa Medical Ab Malmo
|
US
|
OTC
|
|
IDRSF
|
Idorsia Ag
|
US
|
OTC
|
|
IMUC
|
Immunocellular Thera
|
US
|
OTC
|